279 related articles for article (PubMed ID: 11410486)
21. P53 expression and polysomies of chromosome 9, 17 in head and neck cancer prognosis.
Charuruks N; Shin DM; Voravud N; Ro JY; Hong WK; Hittelman WN
J Med Assoc Thai; 1999 May; 82(5):466-76. PubMed ID: 10443096
[TBL] [Abstract][Full Text] [Related]
22. The relationship between allelic imbalance on 17p, p53 mutation and p53 overexpression in head and neck cancer.
Götte K; Riedel F; Neubauer J; Schäfer C; Coy JF; Hörmann K
Int J Oncol; 2001 Aug; 19(2):331-6. PubMed ID: 11445847
[TBL] [Abstract][Full Text] [Related]
23. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
[TBL] [Abstract][Full Text] [Related]
24. Refined characterization of head and neck squamous cell carcinomas expressing a seemingly wild-type p53 protein.
Leng K; Schlien S; Bosch FX
J Oral Pathol Med; 2006 Jan; 35(1):19-24. PubMed ID: 16393249
[TBL] [Abstract][Full Text] [Related]
25. Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis.
Coulet F; Blons H; Cabelguenne A; Lecomte T; Lacourreye O; Brasnu D; Beaune P; Zucman J; Laurent-Puig P
Cancer Res; 2000 Feb; 60(3):707-11. PubMed ID: 10676657
[TBL] [Abstract][Full Text] [Related]
26. Proteomic analysis of field cancerization in pharynx and oesophagus: a prospective pilot study.
Roesch-Ely M; Leipold A; Nees M; Holzinger D; Dietz A; Flechtenmacher C; Wolf T; Zapatka M; Bosch FX
J Pathol; 2010 Aug; 221(4):462-70. PubMed ID: 20593486
[TBL] [Abstract][Full Text] [Related]
27. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.
Gunduz M; Ouchida M; Fukushima K; Ito S; Jitsumori Y; Nakashima T; Nagai N; Nishizaki K; Shimizu K
Oncogene; 2002 Jun; 21(28):4462-70. PubMed ID: 12080476
[TBL] [Abstract][Full Text] [Related]
28. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.
van Houten VM; Leemans CR; Kummer JA; Dijkstra J; Kuik DJ; van den Brekel MW; Snow GB; Brakenhoff RH
Clin Cancer Res; 2004 Jun; 10(11):3614-20. PubMed ID: 15173067
[TBL] [Abstract][Full Text] [Related]
29. Multiple head and neck tumors: evidence for a common clonal origin.
Bedi GC; Westra WH; Gabrielson E; Koch W; Sidransky D
Cancer Res; 1996 Jun; 56(11):2484-7. PubMed ID: 8653681
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of RAD17 in head and neck cancer.
Zhao M; Begum S; Ha PK; Westra W; Califano J
Head Neck; 2008 Jan; 30(1):35-42. PubMed ID: 17657792
[TBL] [Abstract][Full Text] [Related]
31. p53-positive tumor-distant squamous epithelia of the head and neck reveal selective loss of chromosome 17.
Wolf C; Flechtenmacher C; Dietz A; Weidauer H; Abel U; Maier H; Bosch FX
Laryngoscope; 2004 Apr; 114(4):698-704. PubMed ID: 15064627
[TBL] [Abstract][Full Text] [Related]
32. Synchronous oral carcinomas: independent or common clonal origin?
Scholes AG; Woolgar JA; Boyle MA; Brown JS; Vaughan ED; Hart CA; Jones AS; Field JK
Cancer Res; 1998 May; 58(9):2003-6. PubMed ID: 9581845
[TBL] [Abstract][Full Text] [Related]
33. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma.
Yarbrough WG
Laryngoscope; 2002 Dec; 112(12):2114-28. PubMed ID: 12461329
[TBL] [Abstract][Full Text] [Related]
34. Multiple squamous cell carcinomas of the head and neck show different phenotypes of allelic loss patterns suggesting different clonal origin of carcinogenesis.
Shiga K; Ogawa T; Yoshida F; Matsuura K; Tateda M; Saijo S; Miyagi T; Kobayashi T
Anticancer Res; 2003; 23(5A):3911-5. PubMed ID: 14666696
[TBL] [Abstract][Full Text] [Related]
35. The role of genomic instability in the pathogenesis of squamous cell carcinoma of the head and neck.
Wiseman SM; Stoler DL; Anderson GR
Surg Oncol Clin N Am; 2004 Jan; 13(1):1-11. PubMed ID: 15062358
[TBL] [Abstract][Full Text] [Related]
36. Genetic progression model for head and neck cancer: implications for field cancerization.
Califano J; van der Riet P; Westra W; Nawroz H; Clayman G; Piantadosi S; Corio R; Lee D; Greenberg B; Koch W; Sidransky D
Cancer Res; 1996 Jun; 56(11):2488-92. PubMed ID: 8653682
[TBL] [Abstract][Full Text] [Related]
37. Microsatellite analysis of breast carcinoma and corresponding local recurrences.
Regitnig P; Moser R; Thalhammer M; Luschin-Ebengreuth G; Ploner F; Papadi H; Tsybrovskyy O; Lax SF
J Pathol; 2002 Oct; 198(2):190-7. PubMed ID: 12237878
[TBL] [Abstract][Full Text] [Related]
38. Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients.
van Zeeburg HJ; Snijders PJ; Pals G; Hermsen MA; Rooimans MA; Bagby G; Soulier J; Gluckman E; Wennerberg J; Leemans CR; Joenje H; Brakenhoff RH
Cancer Res; 2005 Feb; 65(4):1271-6. PubMed ID: 15735012
[TBL] [Abstract][Full Text] [Related]
39. Allelic loss and tumor pathology in head and neck squamous cell carcinoma.
Rybicki BA; Savera AT; Gomez JA; Patel SC; Ballard NE; Benninger MS; Zarbo RJ; Van Dyke DL
Mod Pathol; 2003 Oct; 16(10):970-9. PubMed ID: 14559979
[TBL] [Abstract][Full Text] [Related]
40. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
Hass HG; Schmidt A; Nehls O; Kaiser S
Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
